M. Zúñiga

Atherogenic Ratios in Patients with Recurrent Acute Coronary Syndrome and Receiving Statin Therapy: Clinical Usefullness as Cardiovascular Predictors

J. Pedro-Botet, X. Pintó, J. Núñez-Cortés, 2014 .

Atherogenic ratios in patients with recurrent acute coronary syndrome and receiving statin therapy: Clinical usefullness as cardiovascular predictors

J. Pedro-Botet, X. Pintó, J. Millán, 2014 .

Management of Dyslipidemia in the Metabolic Syndrome

L. Masana, L. Pallardo, X. Pintó, 2007, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

L. Masana, J. Pedro-Botet, L. Pallardo, 2009, Vascular health and risk management.

[Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome].

A. Jover, A. Hernández-Mijares, X. Pintó, 2011, Revista espanola de cardiologia.

A Very High Prevalence of Low HDL Cholesterol in Spanish Patients With Acute Coronary Syndromes

A. Hernández-Mijares, X. Pintó, J. Millán, 2010, Clinical cardiology.

[Diagnosis of metabolic syndrome. Adaptation of diagnostic criteria in our setting. Recommendations of the HDL forum].

F. Perez-Jimenez, L. Pallardo, X. Pintó, 2006, Revista clínica española (Ed. impresa).

Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention

L. Pallardo, X. Pintó, J. Millán, 2022 .

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

A. Hernández-Mijares, A. Mangas, M. Zúñiga, 2009 .